Kristen Marks, MD, Infectious Disease, New York, NY, New York-Presbyterian Hospital

KristenM.MarksMD

Infectious Disease New York, NY

Assistant Professor, Medicine, Weill Cornell Medical College

Dr. Marks is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Marks' full profile

Already have an account?

Education & Training

  • New York Presbyterian HospitalFellowship, Infectious Disease, 2002 - 2005
  • New York Presbyterian HospitalResidency, Internal Medicine, 1999 - 2002
  • Columbia University College of Physicians & SurgeonsClass of 1999

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2001 - 2021
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
  • Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Benefit of Early Versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis Among People with HIV in the START Randomized Trial  
    Fred Gordin, Kristen Marks, Hepatology

Press Mentions

  • FDA Issues Warning About Hepatitis C Drug as Dozens of Patients Experience Worsening Liver Function
    FDA Issues Warning About Hepatitis C Drug as Dozens of Patients Experience Worsening Liver FunctionAugust 29th, 2019
  • Spotlight on Diversity: Tomorrow’s Leaders Foster Inclusion in Medicine
    Spotlight on Diversity: Tomorrow’s Leaders Foster Inclusion in MedicineApril 30th, 2021
  • Why It Is Vital You Get Your Second Covid Vaccine Dose
    Why It Is Vital You Get Your Second Covid Vaccine DoseApril 17th, 2021
  • Join now to see all

Grant Support

  • Thrombocytopenia &Hiv/Hcv: Risk Factors &TreatmentNational Institute Of Allergy And Infectious Diseases2005–2009
  • Safety/Efficacy Of IV Anti-D For Treatment Of Thrombocytopenia In HCVNational Center For Research Resources2005–2007

Hospital Affiliations